CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance.

Li-Yan QiaoHan-Bing LiYue Zhang Di ShenPeng LiuYi-Qun Che

Published in: Pharmacogenomics and personalized medicine (2021)

CD24 was correlated with better R-CHOP treatment response and tumor immunosuppression in ABC-DLBCL. CD24 may be a promising signal in treatment and prognosis evaluation in ABC-DLBCL patients.

Keyphrases

diffuse large b cell lymphoma
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
combination therapy
patient reported outcomes